PL1464341T3 - Rozpuszczalna w wodzie formulacja zawierająca ubichinon do zastosowania w okulistyce - Google Patents
Rozpuszczalna w wodzie formulacja zawierająca ubichinon do zastosowania w okulistyceInfo
- Publication number
- PL1464341T3 PL1464341T3 PL04101334T PL04101334T PL1464341T3 PL 1464341 T3 PL1464341 T3 PL 1464341T3 PL 04101334 T PL04101334 T PL 04101334T PL 04101334 T PL04101334 T PL 04101334T PL 1464341 T3 PL1464341 T3 PL 1464341T3
- Authority
- PL
- Poland
- Prior art keywords
- ubiquinone
- containing water
- ophthalmic use
- soluble formulation
- formulation
- Prior art date
Links
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title 1
- 235000017471 coenzyme Q10 Nutrition 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 title 1
- 229940035936 ubiquinone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000153A ITRM20030153A1 (it) | 2003-04-03 | 2003-04-03 | Formulazione idrosolubile contenente ubichinone per uso oftalmico. |
| EP04101334A EP1464341B1 (en) | 2003-04-03 | 2004-03-31 | Ubiquinone-containing water-soluble formulation for ophthalmic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1464341T3 true PL1464341T3 (pl) | 2012-10-31 |
Family
ID=29765745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04101334T PL1464341T3 (pl) | 2003-04-03 | 2004-03-31 | Rozpuszczalna w wodzie formulacja zawierająca ubichinon do zastosowania w okulistyce |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1464341B1 (pl) |
| CY (1) | CY1113085T1 (pl) |
| DK (1) | DK1464341T3 (pl) |
| ES (1) | ES2385037T3 (pl) |
| IT (1) | ITRM20030153A1 (pl) |
| PL (1) | PL1464341T3 (pl) |
| PT (1) | PT1464341E (pl) |
| SI (1) | SI1464341T1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10046541A1 (de) * | 2000-09-19 | 2002-03-28 | Knoll Ag | Mechanisch stabile darreichungsformen, enthaltend Ubichinone |
| JP2008514714A (ja) * | 2004-09-30 | 2008-05-08 | イーストマン ケミカル カンパニー | 有意な流出阻害を示さない、親油性薬物を可溶化するビタミンｅｔｐｇｓ分子を含む医薬製剤及びこのような医薬製剤の使用 |
| FR2892936A1 (fr) * | 2005-11-10 | 2007-05-11 | Galderma Res & Dev | Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition. |
| CA2677253C (en) * | 2007-02-01 | 2015-06-30 | National Research Council Of Canada | Formulations of lipophilic bioactive molecules |
| WO2008101344A1 (en) * | 2007-02-22 | 2008-08-28 | Peter Tomlinson | Soluble bioactive lipophilic compounds compositions |
| GB0724772D0 (en) * | 2007-12-19 | 2008-01-30 | Ucl Business Plc | Carrier |
| GB0905348D0 (en) * | 2009-03-27 | 2009-05-13 | Ucl Business Plc | Carrier |
| US9481856B2 (en) * | 2008-06-09 | 2016-11-01 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide |
| RU2445079C2 (ru) * | 2010-06-02 | 2012-03-20 | Общество С Ограниченной Ответственностью "Акцент" | Композиция на основе 6-декапренил-2,3-диметокси-5-метил-1,4-бензохинона и способ ее получения |
| ITRM20120331A1 (it) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
| EP3673896B9 (en) * | 2018-12-28 | 2022-05-18 | Dr. Rolf Lambert Pharma-Consulting GmbH | Liposomial eye drops solution and uses thereof for the treatment of dry eye syndrome |
| DE102021212692A1 (de) | 2021-11-11 | 2023-05-11 | Ursapharm Arzneimittel Gmbh | Selbstemulgierende öl-in wasser-mikro- oder nanoemulsion so-wie emulgierende zusammensetzung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5558876A (en) * | 1995-03-29 | 1996-09-24 | Alcon Laboratories, Inc. | Topical ophthalmic acidic drug formulations |
| IT1307281B1 (it) | 1999-11-25 | 2001-10-30 | Simonelli Giuseppe | Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva, |
| AUPQ761100A0 (en) | 2000-05-18 | 2000-06-08 | Australian Rural Group Limited | Lipophilic medicament |
| ITRM20010755A1 (it) * | 2001-12-20 | 2003-06-20 | Simonelli Giuseppe | Uso del chinone q10 per il trattamento delle malattie oculari. |
-
2003
- 2003-04-03 IT IT000153A patent/ITRM20030153A1/it unknown
-
2004
- 2004-03-31 SI SI200431905T patent/SI1464341T1/sl unknown
- 2004-03-31 ES ES04101334T patent/ES2385037T3/es not_active Expired - Lifetime
- 2004-03-31 EP EP04101334A patent/EP1464341B1/en not_active Expired - Lifetime
- 2004-03-31 PL PL04101334T patent/PL1464341T3/pl unknown
- 2004-03-31 DK DK04101334.3T patent/DK1464341T3/da active
- 2004-03-31 PT PT04101334T patent/PT1464341E/pt unknown
-
2012
- 2012-08-29 CY CY20121100775T patent/CY1113085T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1464341T1 (sl) | 2012-09-28 |
| ES2385037T3 (es) | 2012-07-17 |
| ITRM20030153A0 (it) | 2003-04-03 |
| DK1464341T3 (da) | 2012-07-09 |
| EP1464341A1 (en) | 2004-10-06 |
| EP1464341B1 (en) | 2012-05-30 |
| CY1113085T1 (el) | 2016-04-13 |
| ITRM20030153A1 (it) | 2004-10-04 |
| PT1464341E (pt) | 2012-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2399627B (en) | Ophthalmologic apparatus | |
| IL196021A0 (en) | Pyrazolopyridine derivatives uses | |
| IL166623A0 (en) | Aripiprazole complex formulation | |
| GB0505250D0 (en) | Hydrogel formulations | |
| IL173290A0 (en) | Liquid formulation | |
| GB0319874D0 (en) | Novel formulation | |
| GB0207438D0 (en) | Formulation | |
| GB0318448D0 (en) | Formulation | |
| GB0316206D0 (en) | Pharmaceutical formulation | |
| AU2003226487A8 (en) | Formulation | |
| PL1464341T3 (pl) | Rozpuszczalna w wodzie formulacja zawierająca ubichinon do zastosowania w okulistyce | |
| GB0305679D0 (en) | Agrochemical formulation | |
| GB0312195D0 (en) | Formulation | |
| EP1661573A4 (en) | OPHTHALMIC COMPOSITION | |
| GB0320522D0 (en) | Formulation | |
| GB0307765D0 (en) | Tissue-adhesive formulations | |
| GB2420185B (en) | Ophthalmoscope | |
| EP1647273A4 (en) | OPHTHALMIC COMPOSITION | |
| GB0303876D0 (en) | Formulation | |
| GB2407395B (en) | Ophthalmoscope | |
| GB0318663D0 (en) | Rolling formulation | |
| GB0310881D0 (en) | Pharmaceutical formulation | |
| GB0308978D0 (en) | Formulation | |
| GB0316538D0 (en) | Formulation | |
| ZA200510326B (en) | Dimeticone-containing sustaned formulation |